IBIO
iBio, Inc.
1.10$
-5.9%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | – | 100.0% | – | 100.0% | – | 100.0% | 100.0% | – | – | – | 100.0% | |
| 500.0% | – | – | 160.6% | – | – | – | – | 289.0% | – | – | – | 0.0% | |
| -400.0% | – | – | -60.6% | – | 100.0% | – | 100.0% | -189.0% | – | – | – | 100.0% | |
| 3,212.0% | – | – | 651.4% | – | 938.5% | – | 1,612.0% | 3,550.0% | – | – | – | 19,643.0% | |
| 7,094.0% | – | – | 1,396.6% | – | 1,371.0% | – | 1,087.0% | 2,501.0% | – | – | – | 14,959.0% | |
| 9,806.0% | – | – | 1,887.4% | – | 2,309.5% | – | 2,699.0% | 5,762.0% | – | – | – | 35,241.0% | |
| -10,206.0% | – | – | -1,948.0% | – | -2,209.5% | – | -2,599.0% | -5,951.0% | – | – | – | -35,141.0% | |
| 52.0% | – | – | 34.3% | – | 28.5% | – | 22.0% | 36.0% | – | – | – | 145.0% | |
| -10,148.0% | – | – | -1,854.9% | – | -2,182.0% | – | -2,581.5% | -5,720.0% | – | – | – | -33,044.0% | |
| 1,454.0% | – | – | -741.7% | – | – | – | – | – | – | – | – | – | |
| -11,492.0% | – | – | -4,444.6% | – | -2,182.0% | – | -2,581.5% | -5,720.0% | – | – | – | -33,044.0% | |
| -9,596.0% | – | – | -1,660.0% | – | -2,013.0% | – | -2,417.0% | -5,395.0% | – | – | – | -32,345.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.